Article
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis.
Rheumatology (Oxford, England) - 2 May 2024
Sysojev Anton Öberg, Saevarsdottir Saedis, Diaz-Gallo Lina-Marcela, Silberberg Gilad N, Alfredsson Lars, Klareskog Lars, Baecklund Eva, Björkman Lena, Kastbom Alf, Rantapää-Dahlqvist Solbritt, Turesson Carl, Jonsdottir Ingileif, Stefansson Kari, Frisell Thomas, Padyukov Leonid, Askling Johan, Westerlind Helga
Abstract excerpt
OBJECTIVES: To investigate the influence of genetic factors on persistence with treatment of early RA with MTX monotherapy. METHODS: We conducted a genome-wide association study (GWAS) in a sample of 3902 Swedish early-RA patients initiating MTX in DMARD monotherapy as their first-ever DMARD. The outcome, short- and long-term MTX treatment persistence, was defined as remaining on MTX at 1 and at 3 years,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
